{"id":57783,"date":"2023-03-31T09:49:57","date_gmt":"2023-03-31T13:49:57","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=57783"},"modified":"2025-10-20T17:57:28","modified_gmt":"2025-10-20T21:57:28","slug":"wegovy-vs-ozempic","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/wegovy-vs-ozempic\/","title":{"rendered":"Wegovy vs. Ozempic: Differences, similarities, and which is better for you"},"content":{"rendered":"

If you have Type 2 diabetes or are having trouble managing your weight, you might have heard about two medications that are given as weekly injections: Wegovy<\/a> and Ozempic<\/a>. Both of these drugs can help control blood sugar levels and assist with weight loss<\/a>. However, Wegovy is specifically approved for weight loss, while Ozempic is approved for treating diabetes.<\/span><\/p>\n

Both medications are manufactured by Novo Nordisk and come as prefilled injection pens. They also contain the same active ingredient, semaglutide, which is a <\/span>glucagon-like peptide-1 (GLP-1) receptor agonist<\/span><\/a>. Although they contain the same active ingredient, Wegovy and Ozempic differ in several ways.\u00a0<\/span><\/p>\n

Continue reading to learn about the similarities and differences between Wegovy and Ozempic, including their cost and potential side effects.\u00a0\u00a0<\/span><\/p>\n

What are the main differences between Wegovy and Ozempic?<\/span><\/h2>\n

The main differences between Wegovy and Ozempic lie in their dosages, approved uses, and age restrictions.\u00a0<\/span><\/p>\n

Although they both contain semaglutide, Wegovy is given in higher doses than Ozempic. The maintenance dosage of Wegovy is <\/span>2.4 mg or 1.7 mg once weekly<\/span><\/a>, while the typical maintenance dosage of Ozempic is <\/span>0.5 mg to 1 mg once weekly<\/span><\/a>. However, they are both started at an initial dosage of 0.25 mg once weekly, which is gradually increased to the target dosage.<\/span><\/p>\n

Wegovy is approved by the U.S. Food and Drug Administration (FDA) as a weight loss medication. On the other hand, Ozempic is FDA approved to <\/span>treat Type 2 diabetes<\/span><\/a>, although it is sometimes prescribed off-label <\/span>for weight loss<\/span><\/a>. Wegovy is approved for adults and children 12 and older, while Ozempic is only approved for adults 18 and older.<\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Main differences between Wegovy and Ozempic<\/span><\/h3>\n<\/th>\n<\/tr>\n<\/thead>\n

<\/td>\nWegovy<\/b><\/td>\nOzempic<\/b><\/td>\n<\/tr>\n
Drug class<\/b><\/td>\nGLP-1 agonist<\/span><\/td>\nGLP-1 agonist<\/span><\/td>\n<\/tr>\n
Brand\/generic status<\/b><\/td>\nBrand only<\/span><\/td>\nBrand only<\/span><\/td>\n<\/tr>\n
What is the generic name?<\/b><\/td>\nSemaglutide<\/span><\/td>\nSemaglutide<\/span><\/td>\n<\/tr>\n
What form(s) does the drug come in?<\/b><\/td>\nSubcutaneous injection<\/span><\/td>\nSubcutaneous injection<\/span><\/td>\n<\/tr>\n
What is the standard dosage?<\/b><\/td>\n0.25 mg injected under the skin once weekly for 4 weeks. The dosage is then increased to 0.5 mg once weekly for 4 weeks, 1 mg once weekly for 4 weeks, 1.7 mg once weekly for weeks, and then 2.4 mg once weekly.<\/span><\/td>\n0.25 injected under the skin once weekly for 4 weeks. The dosage is then increased to 0.5 mg once weekly for 4 weeks and then\u00a0 1 mg weekly. The dosage may be increased to 2 mg once weekly after 4 weeks on the 1 mg dosage, depending on the treatment response.<\/span><\/td>\n<\/tr>\n
What does it treat?<\/b><\/td>\nObesity or excess weight with weight-related health conditions<\/span><\/td>\nType 2 diabetes<\/span><\/td>\n<\/tr>\n
How long is the typical treatment?<\/b><\/td>\nLong-term<\/span><\/td>\nLong-term<\/span><\/td>\n<\/tr>\n
Who typically uses the medication?<\/b><\/td>\nAdults and children 12 years and older<\/span><\/td>\nAdults 18 years and older<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Wegovy is FDA approved for managing weight in people who are obese with a <\/span>body mass index (BMI) of 30 or more<\/span><\/a>. It is also approved to manage weight in people who are overweight with a BMI of 27 or more and at least one weight-related condition, such as high cholesterol, high blood pressure, or diabetes.\u00a0<\/span><\/p>\n

In addition to <\/span>chronic weight managemen<\/span><\/a>t, Wegovy is also approved to lower the risk of cardiovascular death, heart attacks, and stroke in people who are obese or overweight with heart disease. Although Wegovy is not approved for Type 2 diabetes, it may be used <\/span>off-label<\/span><\/a> to manage blood sugar levels, especially in people who may also be overweight or obese. It is prescribed to be used along with a reduced-calorie diet and exercise plan.\u00a0<\/span><\/p>\n

Ozempic is FDA approved to treat <\/span>Type 2 diabetes<\/span><\/a>. It is also approved to reduce the risk of major cardiovascular events, such as heart attack, stroke, and cardiovascular death, in people with Type 2 diabetes and heart disease. Due to its effects on weight reduction, some healthcare providers may prescribe <\/span>Ozempic off-label<\/span><\/a> for long-term weight management.\u00a0<\/span><\/p>\n\n\n\n\n\n\n\n
Condition<\/b><\/td>\nWegovy<\/b><\/td>\nOzempic<\/b><\/td>\n<\/tr>\n
Type 2 diabetes<\/span><\/td>\nOff-label<\/span><\/td>\nYes<\/span><\/td>\n<\/tr>\n
Lower the risk of major cardiovascular events, such as heart attack, stroke, and death<\/span><\/td>\nYes<\/span><\/td>\nYes<\/span><\/td>\n<\/tr>\n
Obesity<\/span><\/td>\nYes<\/span><\/td>\nOff-label<\/span><\/td>\n<\/tr>\n
Excess weight with a weight-related condition<\/span><\/td>\nYes<\/span><\/td>\nOff-label<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Is Wegovy or Ozempic more effective?<\/span><\/h2>\n

Both Wegovy and Ozempic are effective when used as directed by a healthcare provider. The most effective drug will depend on what they are used for, a person\u2019s overall condition, and their response to treatment.<\/span><\/p>\n

Wegovy is given at a higher dosage than Ozempic. In other words, it contains a higher strength of semaglutide and is more potent than Ozempic. Wegovy is specifically approved for weight management and is more effective for promoting weight loss than Ozempic.\u00a0<\/span><\/p>\n

Clinical trials show patients who took Wegovy 2.4 mg weekly lost an average of <\/span>around 15%<\/span><\/a> of their body weight after 68 weeks. In the SUSTAIN 3 trial, patients who took 1 mg of Ozempic weekly for 56 weeks lost around <\/span>6% of their body weight<\/span><\/a>.\u00a0<\/span><\/p>\n

Keep in mind, Ozempic is meant to be used as a diabetes medication rather than a weight loss drug. Both drugs should be used alongside lifestyle changes, such as a balanced diet and regular physical activity for maximum effectiveness.\u00a0<\/span><\/p>\n

In addition, other GLP-1 receptor agonists are available, including Trulicity (dulaglutide) and Saxenda (liraglutide). Therefore, you may want to consult a healthcare provider for the best treatment option.\u00a0<\/span><\/p>\n

\t\t